A pilot study to compare natural health product-drug interactions in two databases in Canada
- PMID: 20077138
- DOI: 10.1007/s11096-010-9364-2
A pilot study to compare natural health product-drug interactions in two databases in Canada
Abstract
Objective: The aim of this article is to evaluate and compare two natural health product databases for the purpose of integrating them into a pharmacy information system in Canada.
Methods: This is a descriptive pilot study that compared the Natural Medicine Comprehensive Database (NMCD) and Natural Standard Database (NSD). We randomly chose five hospital patient files. For each drug prescription, we searched for and counted the number of potential natural health product-drug interactions in each database.
Main outcome measure: We compared all of the potential interactions between dexamethasone and the natural health products in both databases. We also evaluated the quality of a selection of references for 30 potential natural health product-dexamethasone interactions.
Results: Five pediatric patient files were selected for a total of 21 different common names. The number of potential natural health product-drug interactions identified varied from 12 (salbutamol-albuterol) to 129 (dexamethasone) in the NSD for an average of 63 +/- 33. The number of potential natural health product-drug interactions identified varied from 1 (salbutamol-albuterol) to 96 (dexamethasone) in the NMCD for an average of 55 +/- 27. There was no significant difference between the average number of potential natural health product-drug interactions between the databases (P = 0.40). The average number of common potential interactions was 9 +/- 8. Thirty potential interactions of dexamethasone were compared. The number of abstracts per pair of interactions varied from 0 (Aloe-dexamethasone in the NSD) to 17 (dexamethasone-St. John's wort in the NMCD). For the 10 pairs that were common to both databases, the number of abstracts given was 4.5 +/- 4.7 for the NMCD and 3.1 +/- 2.1 for the NSD (P = 0.41) and the average evaluation score was 4.6 +/- 1.5 for the NMCD and 5.6 +/- 1.2 for the NSD (P = 0.43).
Conclusion: This pilot study presents a comparison of potential natural health product-drug interactions from two different databases using two different scenarios in a hospital setting. The study reveals a high and variable number of pairs of natural health product-drug interactions per drug between the NSD and the NMCD. Further studies are necessary to evaluate the pertinence and hierarchy of the information offered by suppliers and natural health product databases.
Similar articles
-
An evaluation of pharmacist and health food store retailer's knowledge regarding potential drug interactions associated with St. John's wort.Can J Clin Pharmacol. 2010 Winter;17(1):e57-63. Epub 2010 Feb 5. Can J Clin Pharmacol. 2010. PMID: 20147772
-
Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.J Pharm Pharmacol. 2019 Jan;71(1):129-138. doi: 10.1111/jphp.12858. Epub 2018 Feb 7. J Pharm Pharmacol. 2019. PMID: 29411879 Review.
-
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).Psychopharmacol Bull. 2001 Winter;35(1):53-64. Psychopharmacol Bull. 2001. PMID: 12397870 Review.
-
Community identification of natural health product-drug interactions.Ann Pharmacother. 2007 Jul;41(7):1124-9. doi: 10.1345/aph.1H463. Epub 2007 Jun 19. Ann Pharmacother. 2007. PMID: 17578882
-
Natural Health Product-Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication.J Child Adolesc Psychopharmacol. 2020 Feb;30(1):38-47. doi: 10.1089/cap.2019.0102. Epub 2019 Nov 22. J Child Adolesc Psychopharmacol. 2020. PMID: 31670573
Cited by
-
Identification and evaluation of drug-supplement interactions in Hungarian hospital patients.Int J Clin Pharm. 2014 Apr;36(2):451-9. doi: 10.1007/s11096-014-9923-z. Epub 2014 Feb 23. Int J Clin Pharm. 2014. PMID: 24562975
-
eHealth technologies assisting in identifying potential adverse interactions with complementary and alternative medicine (CAM) or standalone CAM adverse events or side effects: a scoping review.BMC Complement Med Ther. 2020 Jul 29;20(1):239. doi: 10.1186/s12906-020-02963-y. BMC Complement Med Ther. 2020. PMID: 32727531 Free PMC article.
-
A pilot study of website information regarding aromatase inhibitors: dietary supplement interactions.J Altern Complement Med. 2011 Nov;17(11):1043-9. doi: 10.1089/acm.2010.0471. J Altern Complement Med. 2011. PMID: 22087614 Free PMC article.
-
Web-based online resources about adverse interactions or side effects associated with complementary and alternative medicine: a systematic review, summarization and quality assessment.BMC Med Inform Decis Mak. 2020 Nov 9;20(1):290. doi: 10.1186/s12911-020-01298-5. BMC Med Inform Decis Mak. 2020. PMID: 33167980 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources